StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.57−0.17 (-0.86%)

Close on Nov 17, 2026Market cap $1.17BP/E –Yield –

Tyra Biosciences cash

Cash and short-term investments held at the end of each period.

Tyra Biosciences's cash was $73.84M at Jun 30, 2026. For fiscal 2025 it was $77.39M, down 16.8% from the year before. The highest annual figure on record is $302.43M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$77.39M-16.8%
FY2024Dec 31, 2024$92.97M+57.6%
FY2023Dec 31, 2023$59.01M-76.6%
FY2022Dec 31, 2022$252.21M-16.6%
FY2021Dec 31, 2021$302.43M+1855.3%
FY2020Dec 31, 2020$15.47M+14221.3%
FY2019Dec 31, 2019$108.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$73.84M-25.0%
Q1 FY2026Mar 31, 2026$84.96M-15.7%
Q4 FY2025Dec 31, 2025$77.39M-16.8%
Q3 FY2025Sep 30, 2025$61.95M-40.4%
Q2 FY2025Jun 30, 2025$98.49M-1.0%
Q1 FY2025Mar 31, 2025$100.72M-60.4%
Q4 FY2024Dec 31, 2024$92.97M+57.6%
Q3 FY2024Sep 30, 2024$103.89M-51.8%
Q2 FY2024Jun 30, 2024$99.49M-57.2%
Q1 FY2024Mar 31, 2024$254.37M+5.2%
Q4 FY2023Dec 31, 2023$59.01M-76.6%
Q3 FY2023Sep 30, 2023$215.65M-18.1%
Q2 FY2023Jun 30, 2023$232.41M-15.5%
Q1 FY2023Mar 31, 2023$241.70M-17.4%
Q4 FY2022Dec 31, 2022$252.21M-16.6%
Q3 FY2022Sep 30, 2022$263.21M-15.9%
Q2 FY2022Jun 30, 2022$275.11M+103.5%
Q1 FY2022Mar 31, 2022$292.50M+108.0%
Q4 FY2021Dec 31, 2021$302.43M+1855.3%
Q3 FY2021Sep 30, 2021$312.82M+1631.4%
Q2 FY2021Jun 30, 2021$135.20M+125088.9%
Q1 FY2021Mar 31, 2021$140.64M–
Q4 FY2020Dec 31, 2020$15.47M–
Q3 FY2020Sep 30, 2020$18.07M–
Q4 FY2019Dec 31, 2019$108.00K–

More Tyra Biosciences figures

See a number that looks wrong?